MS Clinical Trials

Rick on April 11th, 2010

Ampyra [am-PEER-ah], the brand name for a new drug named fampridine-SR, has been approved by the US Food and Drug Administration for the treatment of Multiple Sclerosis. The new drug is the first Multiple Sclerosis drug to enhance some neurological functioning for MS patients. Dr. Andrew Goodman, chief of the University of Rochester Medical Center’s […]

Continue reading about Ampyra, A New Multiple Sclerosis Drug with Promise

Rick on July 28th, 2008

MS Means – Multiple Sclerosis, your Canadian source for practical MS information Rocky Mountain MS Center Multiple Sclerosis Clinical Trails on – A service of the U.S. National Institutes of Health UCSF Multiple Sclerosis Center

Continue reading about Multiple Sclerosis Links